Bristol-Myers Squibb Company (
) will begin trading ex-dividend on July 02, 2013. A cash dividend
payment of $0.35 per share is scheduled to be paid on August 01,
2013. Shareholders who purchased BMY stock prior to the ex-dividend
date are eligible for the cash dividend payment. This marks the 3rd
quarter that BMY has paid the same dividend. At the current stock
price of $44.69, the dividend yield is 3.13%.
The previous trading day's last sale of BMY was $44.69,
representing a -9.84% decrease from the 52 week high of $49.57 and
a 45.86% increase over the 52 week low of $30.64.
BMY is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). BMY's current earnings per share, an indicator of a company's
profitability, is $.88. Zacks Investment Research reports BMY's
forecasted earnings growth in 2013 as -9.08%, compared to an
industry average of -3.6%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to BMY through an Exchange
Traded Fund [ETF]?
The following ETF(s) have BMY as a top-10 holding:
- iShares U.S. Pharmaceutical ETF (
- PowerShares Dynamic Pharmaceuticals (
- Merrill Lynch Pharmaceutical HOLDRS (
- Select Sector SPDR Fund - Health Care (
- SPDR S&P Pharmaceuticals ETF (
The top-performing ETF of this group is XPH with an increase of
15.56% over the last 100 days. IHE has the highest percent
weighting of BMY at 6.42%.